0
0
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses - Novavax Investor Relations
5/9/23 at 10:29am
Organization
Novavax.com
54 words
0
Comments
This Phase 2 trial is evaluating three vaccine candidates: COVID-Influenza Combination, stand-alone influenza and high-dose COVID Preliminary topline immune responses for all three vaccine...
You are the first to view
https://ir.novavax.com/2023-05-09-Positive-Phase-2-Topline-Results-Show-Novavaxs-COVID-Influenza-Combination,-Stand-alone-Influenza-and-High-dose-COVID-Vaccine-Candidates-Demonstrate-Robust-Immune-Responses
Create an account or login to join the discussion